2018, Number 3
The multidisciplinary treatment of hepatocarcinoma and metastatic renal cancer. Conclusions of the first inter-institutional meeting IMSS-ISSSTE
Pacheco-Pérez R, Rodríguez-Cortés F, Erosa-González M, Erosa-Farah M, González-Herrera J, Palomo-González A, Burgos-Alonso R, Solís-Gasca C, Santana-Valencia J, Cervantes EJM, Cejín-Mil R, Cervera-Cetina A, Guzmán-Jaramillo R, Vivas-Baizal M, Linares-Pérez N, Bolio-Cicero Á, Medina-Rodríguez S, Ardisson-Zamora F, Espinoza-Morales P, Surur-Saibaka E, Bravo-Chang M, Badillo-Alvarado A, Soto-Mendoza M, Moreira-Albores S, Erazo-Valle-Solís A
Full text
Language: Spanish
References: 13
Page: 139-144
PDF size: 102.82 Kb.
ABSTRACT
Cancer is currently the 3rd cause of mortality in Mexico and represents around 12.9% of all cases. Liver and bile duct cancer is set in the third position among leading causes of death in Mexico, surpassed only by lung and prostate cancer. Of all the neoplasms that originate in the liver, approximately 90% corresponds to a hepatocellular carcinoma. Although the incidence and mortality of oncological diseases are decreasing, both parameters are increasing for hepatocellular carcinoma. Since diagnosis is usually made in advanced stages, intention to treatment is rarely offered. Therapeutic options are: liver transplantation, surgical resection, ablation of the tumor by different methods, chemoembolization and radiotherapy, as well as systemic treatment with tyrosine kinase inhibitors and immunotherapy. In the other hand, renal cancer is ranked 4th in mortality due to cancer in Mexico, between men in Yucatán; according to a study conducted in 2018. The diagnosis of cancer is frequent and treatment in the metastatic stages has advanced significantly in recent years. Oncology multidisciplinary committees have been created for better care for the diagnosis, treatment and follow-up of the patients. There is evidence that these type of actions improve decision making in terms of treatment and can improve overall survival. In Mérida, there are different multidisciplinary teams in the regional hospitals of the Mexican Institute of Social Security and in the Institute of Security and Social Services of State Workers, which include medical oncologists, radiation oncologists, surgical oncologists, urologists, gastroenterologists, radiologists and pathologists. The activity of the inter-institutional meeting allows sharing the experience among the health personnel involved in the management of these pathologies to know the current diagnostic scenario, treatment and follow-up of patients, to identify barriers and areas of opportunity, and thus make proposals for improvement in each medical department.REFERENCES
Estadísticas a propósito del... día mundial contra el cáncer (4 de febrero). Datos de Yucatán [Internet]. México: Instituto Nacional de Estadística y Geografía (INEGI) [fecha de publicación: 30 de enero de 2015]. Disponible en: http://www.beta.inegi.org.mx/contenidos/saladeprensa/ aproposito/2015/cancer31.pdf